Canary Capital files for staked Injective ETF – Can INJ target $16 next?

Key Points

1. Canary Capital filed for the first-ever Injective staking ETF in Delaware, potentially boosting INJ's exposure in the U.S. market.

2. INJ's price rose by 8% in the last 24 hours, trading in the $14-$16 range, with a short-term bullish outlook.

3. Injective's DEX volume increased from $393K to $1.1 million daily, and TVL reached $109 million, nearing 2025 highs.

4. The stablecoin market cap on Injective has remained stable between $20 million and $34 million in 2025, with potential for growth through staking.

5. The SEC has yet to confirm receipt of the Injective ETF filing, which could shape INJ's long-term trajectory if approved.